10% ALA光动力疗法治疗中重度痤疮的临床应用研究

2014-04-29 00:44:03万聪翀徐春兴王芳李艳周轶
中国美容医学 2014年20期

万聪翀 徐春兴 王芳 李艳 周轶

[摘要]目的:探讨10% 5-氨基酮戊酸(ALA)光动力疗法治疗中重度痤疮的有效性及安全性。方法:96例中重度痤疮患者,随机分为两组。治疗组:48例,给予5-氨基酮戊酸光动力疗法,每周治疗1次,共治疗3次;对照组:48例,给予红蓝光照射治疗,每周治疗2次,共治疗4~8周。结果:治疗结束后3个月,治疗组有效率为83.00%,对照组为60.87%,两组疗效比较有显著性差异(P<0.05)。治疗组在各个随访期的疗效均明显高于对照组,无明显严重的不良反应。结论:10%的5-氨基酮戊酸光动力疗法治疗中重度痤疮疗效显著,不良反应少。

[关键词]中重度痤疮;5-氨基酮戊酸;光动力疗法;红蓝光

[中图分类号]R758.73+3 [文献标识码]A [文章编号]1008-6455(2014)20-1713-04

Clinical study of photodynamic therapy with 10%ALA in the treatment of moderate to severe acne

WAN Cong-chong, XU Chun-xing, WANG Fang, LI Yan, ZHOU Yi

(Department of Dermatology,The Third Affiliated Hospital of Suzhou University, Changzhou 213003,Jiangsu,China)

Abstract:Objective To investigate the efficacy and safety of 10% 5-aminolevulinic acid (ALA) photodynamic therapy in the treatment of moderate to severe acne. Methods Ninety six patients with moderate to severe acne were randomly divided into two groups.Treatment group (48 cases) was treated with topical ALA-PDT for 3 sessions with all interval of 1 week.The control group (48 cases) was treated with Red and blue light for twice a week for 4~8 weeks. Results Three months after the last treatment,the effective rate of Treatment group was 83.00%,the effective rate of Control group was 60.87%(P<0.05),Therapeutic efficacy of the treatment group at each follow-up period were significantly higher.Treatment group had no serious adverse events compared with the control group.Conclusion Significant effect and fewer adverse reactions were observed in 10%ALA photodynamic therapy in the treatment of severe acne.

Key words:moderate to severe acne; 5-Aaminolevulinic acid;photodynamic therapy; red and blue light

痤疮是多种致病因素(包括皮脂腺分泌过度、毛囊上皮角化过度、痤疮丙酸杆菌过度增殖及炎性反应)共同作用而引起的毛囊皮脂腺慢性炎症性疾病,其病程慢,易复发。5-氨基酮戊酸光动力疗法(ALA-PDT)治疗痤疮是目前痤疮治疗领域的新技术,2012年3月~2013年9月,笔者科室采用10% ALA光动力疗法治疗中重度痤疮患者,并与单纯红蓝光照射法进行比较,现将结果报道如下。

1 对象和方法

1.1研究对象:选取2012年3月~2013年9月在笔者科室门诊就诊者,参考Cunliffe分级法(轻度:以白头及黑头粉刺为主;中度:以炎性丘疹及脓疱为主;重度:炎性丘疹严重,以结节及炎性囊肿为主)进行诊断及分级[1],确诊为中、重度痤疮患者96例。同时要求:①受试者2个月内未进行痤疮相关治疗(包括口服或外用维A酸类药物、糖皮质激素、抗生素及其他治疗)且从未进行光动力治疗;②排除妊娠、哺乳期、口服避孕药患者;③未患有其他面部皮肤疾病(如日光性皮炎、面部银屑病、脂溢性皮炎、湿疹等)患者;……

登录APP查看全文